HomeAI · summaries
Storia in 2 fonti
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology
- ·
benzinga.com
Summit Therapeutics Says Ivonescimab Combination Extends Progression-Free Survival in Lung Cancer Patient
Summit Therapeutics reported positive Phase 3 trial results for ivonescimab, extending progression-free survival in lung cancer patients.
